Until now, the specific pathogenesis of
silicosis is not clear. Exosomal
miRNAs, as a newly discovered intercellular communication medium, play an important role in many diseases. Our previous research found that serum exosomal miR125a-5p was increased in
silicosis patients by
miRNAs high-throughput sequencing.
TRAF6, is a target gene of miR125a-5p, which is involved in T-cell differentiation. Furthermore, results from animal study indicate that knockdown of miR-125a-5p can regulate T lymphocyte subsets and significantly reduce
pulmonary fibrosis by targeting
TRAF6. However, the level of serum exosomal miR125a-5p in
silicosis patients has not been reported, the role of macrophages-secreted exosomal miR-125a-5p in regulating T cell differentiation to promote fibroblast transdifferentiation (FMT) remains unknown. In this study, the levels of serum exosomal miR125a-5p and serum TGF-β1,
IL-17A,
IL-4 cytokines in
silicosis patients were elevated, with the progression of
silicosis, the level of serum exosomal miR125a-5p and serum
IL-4 were increased; thus, the serum level of IFN-γ was negatively correlated with the progression of
silicosis. In vitro, the levels of miR125a-5p in macrophages, exosomes, and T cells stimulated by
silica were significantly increased. When the mimic was transfected into T cells, which directly suppressed
TRAF6 and caused the imbalance of T cells differentiation, induced FMT. To sum up, these results indicate that exosomal miR-125a-5p may by targeting
TRAF6 of T cells, induces the activation and apoptosis of T cells and the remodeling of Th1/Th2 and Th17/Tregs distribution, ultimately promotes FMT. Suggesting that exosomal miR-125a-5p may be a potential therapeutic target for
silicosis.